메뉴 건너뛰기




Volumn 86, Issue 11, 2002, Pages 1667-1669

Why hasn't the National Institute been 'NICE' to patients with colorectal cancer?

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; RALTITREXED;

EID: 0037024432     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600369     Document Type: Editorial
Times cited : (8)

References (13)
  • 4
    • 0037024412 scopus 로고    scopus 로고
    • Clinical and economic benefits of irinotecan in combination with 5-fluorouracil and folinic acid as first line treatment of metastatic colorectal cancer
    • (2002) Br J Cancer , vol.86 , Issue.11 , pp. 1677-1683
    • Cunningham, D.1    Falk, S.2    Jackson, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.